References
- Bonnar J. Haemostasis and coagulation disorders in pregnancy. In Bloom AL, Thomas DP, eds. Haemostasis and Thrombosis. Edinburgh: Churchill Livingstone, 1987: 570–84.
- Wiman B, Csemiczky G, Marsk L, Robbe H. The fast inhibitor of tissue plasminogen activator in plasma during pregnancy. Thromb Haemost 1984; 52: 124–6.
- Kruithof EKO, Tran-Thang C, Gudinchet A, Hauert J, Nicoloso G, Genton C et al. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood 1987; 69: 460–6.
- Ȧstedt B, Lecander I, Ny T. The placental type plasminogen activator inhibitor, PAI-2. Fibrinolysis 1987; 1: 203–8.
- Wiman B, Rånby M. Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay. Thromb Haemost 1986; 55: 189–93.
- Dawie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991; 30: 10363–70.
- Vermylen J, de Vreker RA, Verstraete M. A rapid enzymatic method for assay of fibrinogen, fibrin polymerization time (FPT test). Clin Chim Acta 1973; 8: 418–24.
- Abildgaard U, Lie M, Odegaard OR. Antithrombin (heparin co-factor) assay with ‘new’ chromogenic substrates (S-2238 and chromozyn TH). Thromb Res 1977; 11: 549–53.
- Graeff H, von Hugo R. Fibrinogen derivatives in a case of abruptio placentae. Am J Obstet Gynecol 1974; 120: 335–40.
- Hafter R, Graeff H. Molecular aspects of defibrination in a reptilasetreated case of ‘dead fetus syndrome’. Thromb Res 1975; 7: 391–9.
- Weenink GH, Treffers PE, Viijn P et al. Antithrombin levels in preeclampsia correlated with maternal and fetal morbidity. Am J Obstet Gynecol 1984; 148: 1092–7.
- Weiner CT, Kwaan HC, Xu C, Paul M, Burmeister C, Huck W. Antithrombin III activity in women with hypertension during pregnancy. Obstet Gynecol 1985; 65: 301–6.
- Bredbacka S, Edner G. Soluble fibrin and D-dimer as detectors of hypercoagulability in patients with isolated brain trauma. J Neurosurg Anesthesiol 1994; 6: 75–82.
- Stirling Y, Woolf L, North WRS, Segatchian MJ, Neade TW. Haemostasis in normal pregnancy. Thromb Haemost 1984; 52: 176–82.
- Steichele DF. Consumptive coagulopathy in obstetrics and gynecology. Thromb Diath Haemorrh 1969; Suppl 36: 177.
- Hafter R, Graeff H. Molecular aspects of defibrination in a reptilasetreated case of ‘dead fetus syndrome’. Thromb Res 1975; 7: 391.
- Bonnar J, McNicol GP, Douglas AS. Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia. Br Med J 1971; 1: 12.
- Roberts JM, May WJ. Consumption coagulopathy in severe preeclampsia. Obstet Gynecol 1976; 48: 163.
- Wright JG, Cooper P, Ȧstedt B et al. Fibrinolysis during normal human pregnancy; Complex interrelationships between tissue plasminogen activator and inhibitors and euglobin clot lysis time. Br J Haematol 1988; 69: 253–8.
- Chao-Hung Ho, Zwa-Ling Yan. The predictive value of the hemostasis parameters in the development of preeclampsia. Thromb Haemost 1992; 67(2): 214–18.
- Bredbacka S, Blombäck M, Wiman B. Soluble fibrin: a predictor for the development and outcome of multiple organ failure. Am J Hematol 1994; 46: 289–94.
- Bredbacka S, Blombäck M, Wiman B, Pelzer H. Laboratory methods for detecting disseminated intravascular coagulation (DIC): new aspects. Acta Anaesthesiol Scand 1993; 37: 125–30.